Article
LKB1, TP16, EGFR, and KRAS somatic mutations in lung adenocarcinomas from a Chiba Prefecture, Japan cohort.
Drug discoveries & therapeutics - 1 Feb 2012
Suzuki Y, Oonishi T, Kudo T, Doi H
Abstract excerpt
The discovery of somatic mutations in cancer-related genes has been applied to understand the genetic basis of cancer. Here we report somatic mutations of two tumor suppressor genes: LKB1 (exons 1, 4, and 8) and TP16 (CDKN2A) (exons 1 and 2); and two oncogenes: epidermal growth factor receptor EGFR (exons 18-21) and KRAS (exon 2) in 97 lung adenocarcinoma tissues in a cohort from the Kujukuri coast area of Chiba,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
